Early pregnancy failure is the most common complication of pregnancy, and 1% to 2% of all pregnancies will be ectopic. As one of the leading causes of maternal morbidity and mortality, diagnosing ectopic pregnancy and determining the fate of a pregnancy of unknown location are of great clinical concern. Several serum and plasma biomarkers for ectopic pregnancy have been investigated independently and in combination. The following is a review of the state of biomarker discovery and development for ectopic pregnancy and pregnancy of unknown location. (Fertil Steril (R) 2013;99:1107-16. (C) 2013 by American Society for Reproductive Medicine.)
机构:
Inst Argentino Diagnost & Tratamiento, Buenos Aires, Argentina
Marcelo Torcuato de Alvear 2439, RA-1122 Buenos Aires, ArgentinaInst Argentino Diagnost & Tratamiento, Buenos Aires, Argentina
Larrea, Agustina L.
Bozza, Lorena A.
论文数: 0引用数: 0
h-index: 0
机构:
Inst Argentino Diagnost & Tratamiento, Buenos Aires, ArgentinaInst Argentino Diagnost & Tratamiento, Buenos Aires, Argentina